MYRIAD GENETICS, INC. Goodwill and Intangible Asset Impairment
MYRIAD GENETICS, INC. (MYGN) reported Goodwill and Intangible Asset Impairment of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GoodwillAndIntangibleAssetImpairment · last filed 2026-07-31
- MYRIAD GENETICS, INC. goodwill and intangible asset impairment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- MYRIAD GENETICS, INC. goodwill and intangible asset impairment for the quarter ending 2026-03-31 was $5.40M.
- MYRIAD GENETICS, INC. goodwill and intangible asset impairment for the quarter ending 2025-12-31 was $2.70M, a 93.72% decline year-over-year.
- MYRIAD GENETICS, INC. goodwill and intangible asset impairment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- MYRIAD GENETICS, INC. goodwill and intangible asset impairment for fiscal 2025 was $319.40M, a 462.32% increase from fiscal 2024.
- MYRIAD GENETICS, INC. goodwill and intangible asset impairment for fiscal 2024 was $56.80M.
- MYRIAD GENETICS, INC. goodwill and intangible asset impairment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- MYRIAD GENETICS, INC. goodwill and intangible asset impairment for fiscal 2022 was $16.90M, a 838.89% increase from fiscal 2021.
| Period end | Goodwill and Intangible Asset Impairment 3 month | Goodwill and Intangible Asset Impairment 6 month | Goodwill and Intangible Asset Impairment 9 month | Goodwill and Intangible Asset Impairment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-31 | $5.40M 10-Q · filed 2026-07-31 | $8.10M derived: sum of 3 quarters · filed 2026-07-31 | $8.10M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $5.40M 10-Q · filed 2026-05-06 | $8.10M derived: sum of 2 quarters · filed 2026-05-06 | $8.10M derived: sum of 3 quarters · filed 2026-05-06 | $324.80M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.70M derived: sum of 2 quarters · filed 2026-02-24 | $319.40M derived: sum of 3 quarters · filed 2026-07-31 | $319.40M 10-K · filed 2026-02-24 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-04 | $316.70M derived: sum of 2 quarters · filed 2026-07-31 | $316.70M 10-Q · filed 2025-11-04 | $359.70M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $316.70M 10-Q · filed 2026-07-31 | $316.70M 10-Q · filed 2026-07-31 | $359.70M derived: sum of 3 quarters · filed 2026-07-31 | $361.90M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $43.00M derived: sum of 2 quarters · filed 2026-05-06 | $45.20M derived: sum of 3 quarters · filed 2026-05-06 | $56.80M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $45.20M derived: sum of 2 quarters · filed 2026-02-24 | $56.80M derived: sum of 3 quarters · filed 2026-02-24 | $56.80M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.20M 10-Q · filed 2025-11-04 | $13.80M derived: sum of 2 quarters · filed 2025-11-04 | $13.80M 10-Q · filed 2025-11-04 | $15.00M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $11.60M 10-Q · filed 2025-08-06 | $11.60M 10-Q · filed 2025-08-06 | $12.80M derived: sum of 3 quarters · filed 2026-02-24 | $12.80M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $1.20M 10-Q · filed 2024-05-08 | $1.20M derived: sum of 2 quarters · filed 2026-02-24 | $1.20M derived: sum of 3 quarters · filed 2026-02-24 | $1.20M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $6.20M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $6.20M derived: sum of 3 quarters · filed 2025-02-28 | $6.20M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $6.20M derived: sum of 2 quarters · filed 2025-02-28 | $6.20M derived: sum of 3 quarters · filed 2025-02-28 | $6.20M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.20M derived: sum of 2 quarters · filed 2025-02-28 | $6.20M derived: sum of 3 quarters · filed 2025-02-28 | $16.90M 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $10.70M 10-Q · filed 2023-11-07 | $10.70M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | $10.70M 10-Q · filed 2023-08-04 | $10.70M derived: sum of 3 quarters · filed 2024-02-28 | $10.70M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $10.70M 10-Q · filed 2023-05-04 | $10.70M derived: sum of 2 quarters · filed 2024-02-28 | $10.70M derived: sum of 3 quarters · filed 2024-02-28 | $12.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $1.80M derived: sum of 3 quarters · filed 2024-02-28 | $1.80M 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 | $1.80M derived: sum of 2 quarters · filed 2021-11-04 | $1.80M 10-Q · filed 2021-11-04 | $1.80M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $1.80M 10-Q · filed 2021-08-04 | $1.80M 10-Q · filed 2021-08-04 | $1.80M derived: sum of 3 quarters · filed 2023-03-01 | $1.80M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-05 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $98.40M 10-K · filed 2022-02-25 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $98.40M 10-Q · filed 2021-11-04 | $99.70M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-04 | $98.40M 10-Q · filed 2021-08-04 | $99.70M derived: sum of 3 quarters · filed 2021-08-04 | $99.70M 10-K · filed 2023-03-01 |
| 2020-03-31 | $98.40M 10-Q · filed 2021-05-05 | $99.70M derived: sum of 2 quarters · filed 2021-05-05 | $99.70M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.30M 10-KT · filed 2021-03-16 | $1.30M 10-K · filed 2022-02-25 | ||
| 2019-09-30 | $0.00 10-KT · filed 2021-03-16 | |||
| 2019-06-30 | $0.00 10-K · filed 2022-02-25 | |||
| 2018-06-30 | $0.00 10-KT · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |